Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy

• Main Authors: Lim, I-Liang, Loo, Angela Voon Pei, Subrayan, Visvaraja, Khang, Tsung Fei, See, Mee Hoong, Alip, Adlinda, Taib, Nur Aishah Mohd
• Format: Article
• Published: Elsevier 2018
• Subjects: Q Science (General); QA Mathematics; R Medicine
• Online Access: http://eprints.um.edu.my/21454/; https://doi.org/10.1016/j.breast.2018.04.003

It is now increasingly common for breast cancer patients to receive adjuvant tamoxifen therapy for a period of up to 10 years. As survival rate increases, managing tamoxifen ocular toxicities is important for patients' quality of life. Macular pigments in photoreceptor cells protect against fre...